Johnson & Johnson
Income Statement
| Line Item | FY2007 |
|---|---|
| Revenue | $61.10B |
| Consumer Health | — |
| Pharmaceutical / Innovative Medicine | — |
| Medical Devices / MedTech | — |
| Cost of Revenue | $17.75B |
| Gross Profit | $43.34B |
| Gross Margin | 70.9% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $20.45B |
| Operating Income | $13.58B |
| Operating Margin | 22.2% |
| Interest Expense | $296.0M |
| Pretax Income | $13.28B |
| Income Tax Expense | $2.71B |
| Net Income | $10.58B |
| Net Margin | 17.3% |
| EPS (Basic) | $3.67 |
| EPS (Diluted) | $3.63 |
| Shares Outstanding (Basic) | 2.88B |
| Shares Outstanding (Diluted) | 2.91B |
| Dividends Per Share | $1.62 |